Discovering novel therapeutics for the treatment of neurodegenerative disorders

Signum Biosciences

Through research on protein networks that control biological systems, Signum is developing therapeutic agents for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.

Signum Dermalogix

Signum Biosciences spin out, Signum Dermalogix, is focused on developing new and innovative dermatological products with a commitment to quality, efficacy and safety.

Signum Nutralogix

Signum Biosciences spin out, Signum Nutralogix, is dedicated to developing innovative dietary supplements for enhancing brain health and promoting overall better health.

Research and Funding Provided by: